Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial

BACKGROUND: Tiotropium is an anticholinergic bronchodilator for symptom relief and reducing exacerbations with an established safety profile in patients with chronic obstructive pulmonary disease (COPD). Using data from the 4-year Understanding Potential Long-term Impacts on Function with Tiotropium...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashkin, Donald P, Leimer, Inge, Metzdorf, Norbert, Decramer, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475325/
https://www.ncbi.nlm.nih.gov/pubmed/26031308
http://dx.doi.org/10.1186/s12931-015-0216-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475325/
https://www.ncbi.nlm.nih.gov/pubmed/26031308
http://dx.doi.org/10.1186/s12931-015-0216-4

Ejemplares similares